Home

respirare Tesoro Salutare borsa molmed Paine Gillic Fondi adottare

Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR  RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA
Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA

MolMed now part of AGC Biologics | LinkedIn
MolMed now part of AGC Biologics | LinkedIn

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY  OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER

Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE

Aptamer-Based Antibacterial and Antiviral Therapy against Infectious  Diseases | Journal of Medicinal Chemistry
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases | Journal of Medicinal Chemistry

Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR  RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART

Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their  Association with Age-Related Disorders
Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders

Relazione sulla Remunerazione MolMed S.p.A.
Relazione sulla Remunerazione MolMed S.p.A.

Ultime Notizie Molmed News
Ultime Notizie Molmed News

European Population Genetic Substructure: Further Definition of Ancestry  Informative Markers for Distinguishing among Diverse European Ethnic Groups  | Molecular Medicine | Full Text
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text

MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK  for high-risk leukaemia in the United States
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States

1 - [Note: this notice is the English translation of the official version  of the 102 notice which will be in Italian language]
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]

Sergio Signore (@signore_sergio) / Twitter
Sergio Signore (@signore_sergio) / Twitter

Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed:  the Board of Directors approves the Issuer's not
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not

MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener

MolMed - Wikipedia
MolMed - Wikipedia

COMUNICATO STAMPA
COMUNICATO STAMPA

Overview of the Italian Primary Markets
Overview of the Italian Primary Markets

Will MolMed soon have its first Cell therapy on the Market?
Will MolMed soon have its first Cell therapy on the Market?

European Population Genetic Substructure: Further Definition of Ancestry  Informative Markers for Distinguishing among Diverse European Ethnic Groups  | Molecular Medicine | Full Text
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text

Frontiers | Modulation of Reactive Oxygen Species Homeostasis as a  Pleiotropic Effect of Commonly Used Drugs
Frontiers | Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs

MolMed - YouTube
MolMed - YouTube

I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa
I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa

Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza  - Affaritaliani.it
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it

European Population Genetic Substructure: Further Definition of Ancestry  Informative Markers for Distinguishing among Diverse European Ethnic Groups  | Molecular Medicine | Full Text
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text